Global Brucellosis Vaccines Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Brucellosis Vaccines market size will reach 13.23 Million USD in 2025 and is projected to reach 17.32 Million USD by 2032, with a CAGR of 3.92% (2025-2032). Notably, the China Brucellosis Vaccines market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Brucellosis vaccines are immunizations designed to protect against brucellosis, a bacterial infection caused by species of the Brucella genus. Brucellosis affects various animals, including livestock such as cattle, goats, and pigs, as well as humans. The vaccines developed for brucellosis primarily target livestock populations, as they play a significant role in transmission to humans through consumption of contaminated animal products. Brucellosis vaccines are typically composed of live attenuated or inactivated Brucella strains, which stimulate the immune system to produce protective antibodies against the bacteria. These vaccines are administered to animals, either as a single-dose or multiple-dose regimen, to prevent or reduce the incidence of brucellosis in livestock populations. Vaccination programs are crucial in controlling and eradicating brucellosis, as they help reduce the spread of the disease, minimize economic losses in livestock production, and prevent zoonotic infections in humans. Effective brucellosis vaccines are an essential tool in managing this globally significant bacterial infection.
The major global suppliers of Brucellosis Vaccines include Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, Vetal Company, CZ Veterinaria, SYVA Laboratorios, Indian Immunologicals, Qilu, Tecnovax, Zoetis, Hester Biosciences, Onderstepoort Biological, Instituto Rosenbusch, Ceva Sante Animale, Calier & Biologicos Laverlam, Biovet, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Brucellosis Vaccines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Brucellosis Vaccines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Brucellosis Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Brucellosis Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Brucellosis Vaccines Include:
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Zoetis
Hester Biosciences
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
Brucellosis Vaccines Product Segment Include:
S19 Vaccine
RB51 Vaccine Strain
Brucellosis Vaccines Product Application Include:
Cattle
Sheep
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Brucellosis Vaccines Industry PESTEL Analysis
Chapter 3: Global Brucellosis Vaccines Industry Porter's Five Forces Analysis
Chapter 4: Global Brucellosis Vaccines Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Brucellosis Vaccines Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Brucellosis Vaccines Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Brucellosis Vaccines Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Brucellosis Vaccines market size will reach 13.23 Million USD in 2025 and is projected to reach 17.32 Million USD by 2032, with a CAGR of 3.92% (2025-2032). Notably, the China Brucellosis Vaccines market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Brucellosis vaccines are immunizations designed to protect against brucellosis, a bacterial infection caused by species of the Brucella genus. Brucellosis affects various animals, including livestock such as cattle, goats, and pigs, as well as humans. The vaccines developed for brucellosis primarily target livestock populations, as they play a significant role in transmission to humans through consumption of contaminated animal products. Brucellosis vaccines are typically composed of live attenuated or inactivated Brucella strains, which stimulate the immune system to produce protective antibodies against the bacteria. These vaccines are administered to animals, either as a single-dose or multiple-dose regimen, to prevent or reduce the incidence of brucellosis in livestock populations. Vaccination programs are crucial in controlling and eradicating brucellosis, as they help reduce the spread of the disease, minimize economic losses in livestock production, and prevent zoonotic infections in humans. Effective brucellosis vaccines are an essential tool in managing this globally significant bacterial infection.
The major global suppliers of Brucellosis Vaccines include Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, Vetal Company, CZ Veterinaria, SYVA Laboratorios, Indian Immunologicals, Qilu, Tecnovax, Zoetis, Hester Biosciences, Onderstepoort Biological, Instituto Rosenbusch, Ceva Sante Animale, Calier & Biologicos Laverlam, Biovet, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Brucellosis Vaccines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Brucellosis Vaccines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Brucellosis Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Brucellosis Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Brucellosis Vaccines Include:
Jinyu
Colorado Serum
Boehringer Ingelheim
Biogenesis-Bago
Vetal Company
CZ Veterinaria
SYVA Laboratorios
Indian Immunologicals
Qilu
Tecnovax
Zoetis
Hester Biosciences
Onderstepoort Biological
Instituto Rosenbusch
Ceva Sante Animale
Calier & Biologicos Laverlam
Biovet
Brucellosis Vaccines Product Segment Include:
S19 Vaccine
RB51 Vaccine Strain
Brucellosis Vaccines Product Application Include:
Cattle
Sheep
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Brucellosis Vaccines Industry PESTEL Analysis
Chapter 3: Global Brucellosis Vaccines Industry Porter's Five Forces Analysis
Chapter 4: Global Brucellosis Vaccines Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Brucellosis Vaccines Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Brucellosis Vaccines Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Brucellosis Vaccines Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Brucellosis Vaccines Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Brucellosis Vaccines Product by Type
- 1.2.1 S19 Vaccine
- 1.2.2 RB51 Vaccine Strain
- 1.3 Brucellosis Vaccines Product by Application
- 1.3.1 Cattle
- 1.3.2 Sheep
- 1.3.3 Others
- 1.4 Global Brucellosis Vaccines Market Size Analysis (2020-2032)
- 1.5 Brucellosis Vaccines Market Development Status and Trends
- 1.5.1 Brucellosis Vaccines Industry Development Status Analysis
- 1.5.2 Brucellosis Vaccines Industry Development Trends Analysis
- 2 Brucellosis Vaccines Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Brucellosis Vaccines Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Brucellosis Vaccines Market Analysis by Country
- 4.1 Global Brucellosis Vaccines Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Brucellosis Vaccines Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Brucellosis Vaccines Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.5 China Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.6 France Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.14 India Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Brucellosis Vaccines Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Brucellosis Vaccines Market Revenue by Key Suppliers (2021-2025)
- 5.2 Brucellosis Vaccines Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Brucellosis Vaccines Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Brucellosis Vaccines Market Analysis by Type
- 6.1 Global Brucellosis Vaccines Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Brucellosis Vaccines Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Jinyu
- 7.1.1 Jinyu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Jinyu Brucellosis Vaccines Product Portfolio
- 7.1.3 Jinyu Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Colorado Serum
- 7.2.1 Colorado Serum Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Colorado Serum Brucellosis Vaccines Product Portfolio
- 7.2.3 Colorado Serum Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Boehringer Ingelheim
- 7.3.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Boehringer Ingelheim Brucellosis Vaccines Product Portfolio
- 7.3.3 Boehringer Ingelheim Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Biogenesis-Bago
- 7.4.1 Biogenesis-Bago Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Biogenesis-Bago Brucellosis Vaccines Product Portfolio
- 7.4.3 Biogenesis-Bago Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Vetal Company
- 7.5.1 Vetal Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Vetal Company Brucellosis Vaccines Product Portfolio
- 7.5.3 Vetal Company Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 CZ Veterinaria
- 7.6.1 CZ Veterinaria Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 CZ Veterinaria Brucellosis Vaccines Product Portfolio
- 7.6.3 CZ Veterinaria Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 SYVA Laboratorios
- 7.7.1 SYVA Laboratorios Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 SYVA Laboratorios Brucellosis Vaccines Product Portfolio
- 7.7.3 SYVA Laboratorios Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Indian Immunologicals
- 7.8.1 Indian Immunologicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Indian Immunologicals Brucellosis Vaccines Product Portfolio
- 7.8.3 Indian Immunologicals Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Qilu
- 7.9.1 Qilu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Qilu Brucellosis Vaccines Product Portfolio
- 7.9.3 Qilu Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Tecnovax
- 7.10.1 Tecnovax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Tecnovax Brucellosis Vaccines Product Portfolio
- 7.10.3 Tecnovax Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Zoetis
- 7.11.1 Zoetis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Zoetis Brucellosis Vaccines Product Portfolio
- 7.11.3 Zoetis Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Hester Biosciences
- 7.12.1 Hester Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Hester Biosciences Brucellosis Vaccines Product Portfolio
- 7.12.3 Hester Biosciences Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Onderstepoort Biological
- 7.13.1 Onderstepoort Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Onderstepoort Biological Brucellosis Vaccines Product Portfolio
- 7.13.3 Onderstepoort Biological Brucellosis Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Instituto Rosenbusch
- 7.14.1 Instituto Rosenbusch Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Instituto Rosenbusch Brucellosis Vaccines Product Portfolio
- 7.14.3 Instituto Rosenbusch Brucellosis Vaccines Market Data Analysis (Revenue, Gross Marg
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
